MIRONE, VINCENZO
MIRONE, VINCENZO
DIPARTIMENTO DI NEUROSCIENZE E SCIENZE RIPRODUTTIVE ED ODONTOSTOMATOLOGICHE
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors
2013 Donnarumma, Erminia; D'EMMANUELE DI VILLA BIANCA, Roberta; Mitidieri, Emma; Fusco, Ferdinando; Mirone, Vincenzo; Cirino, Giuseppe; Sorrentino, Raffaella
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study.
2009 Cantiello, Francesca; Imperatore, V; Iannuzzo, M; Scibelli, G; Di Meo, S; Fusco, Ferdinando; Imbimbo, Ciro; Mirone, Vincenzo
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study.
2008 Di Lorenzo, G; Figg, Wd; Fossa, Sd; Mirone, Vincenzo; Autorino, R; Longo, Nicola; Imbimbo, Ciro; Perdonà, S; Giordano, A; Giuliano, Mario; Labianca, R; DE PLACIDO, Sabino
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.
2009 Mirone, Vincenzo; Fusco, Ferdinando; Taglialatela, D; Verze, Paolo; Di Vito, C; Lotti, T; Imbimbo, Ciro
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
2009 Fusco, Ferdinando; Sicuteri, R; Rossi, A; Kontodimas, S; Haro, Jm; Imbimbo, Ciro; Mirone, Vincenzo
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals.
2009 Imbimbo, Ciro; Verze, P; Palmieri, Alessandro; Longo, Nicola; Fusco, Ferdinando; Arcaniolo, D; Mirone, Vincenzo
Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients
2009 Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, N; Imbimbo, Ciro; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?
2010 Novara, G; Ficarra, V; Antonelli, A; Artibani, W; Bertini, R; Carini, M; Cosciani Cunico, S; Imbimbo, Ciro; Longo, Nicola; Martignoni, G; Martorana, G; Minervini, A; Mirone, Vincenzo; Montorsi, F; Schiavina, R; Simeone, C; Serni, S; Simonato, A; Siracusano, S; Volpe, A; Carmignani, G.
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition.
2010 Fusco, Ferdinando; Razzoli, E; Imbimbo, Ciro; Rossi, A; Verze, Paolo; Mirone, Vincenzo
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation
2003 Perretti, A.; Catalano, A.; Mirone, Vincenzo; Imbimbo, C.; Balbi, P.; Palmieri, A.; Longo, N.; Mirone, V.
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas
1999 Cindolo, L.; Benvenuto, G.; Salavatore, P.; Pero, Raffaela; Salvatore, G.; Mirone, Vincenzo; Prezioso, D.
Determinants of Erectile Dysfunction Risk in a Large Series of Italian Men Attending Andrology Clinics
2004 Mirone, Vincenzo; Ricci, E.; Gentile, V.; Basile Fasolo, C.; Parazzini, F.; Calabrese, M.
Frequency and determinants of erectile dysfunction in Italy
2000 Mirone, Vincenzo; Colli, E.; Parazzini, F.
Androgens and benign prostatic hyperplasia
2006 Mirone, Vincenzo; Fusco, Ferdinando; Verze, P.; Schulman, C.; Debruyne, F.; Imbimbo, Ciro
The benefits of dual inhibition of 5 alpha reductase
2006 B., Djavan; Mirone, Vincenzo
How do new data from clinical trials allow us to optimise the assessment and treatment of patients with benign prostatic hyperplasia?
2007 Mirone, Vincenzo
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression
2001 Stanzione, R.; Picascia, A.; Chieffi, P.; Imbimbo, Ciro; Palmieri, A.; Mirone, Vincenzo; Staibano, S.
Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study.
2003 Ricci, E; Parazzini, F; Mirone, Vincenzo; Imbimbo, C; Palmieri, A; Bortolotti, A; DI CINTIO, E; Landoni, M; Lavezzari, M.
Erectile dysfunction after surgical treatment.
2003 Mirone, Vincenzo; Imbimbo, C; Palmieri, A; Longo, N; Fusco, Ferdinando
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation.
2003 Perretti, A; Catalano, A; Mirone, Vincenzo; Imbimbo, C; Balbi, P; Palmieri, A; Longo, N; Fusco, Ferdinando; Verze, P; Santoro, Lucio
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors | 4.2 Abstract in Atti di convegno | 2013 | Donnarumma, Erminia; D'EMMANUELE DI VILLA BIANCA, Roberta; Mitidieri, Emma; Fusco, Ferdinando; Mirone, Vincenzo; Cirino, Giuseppe; Sorrentino, Raffaella | |
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. | 1.1 Articolo in rivista | 2009 | Cantiello, Francesca; Imperatore, V; Iannuzzo, M; Scibelli, G; Di Meo, S; Fusco, Ferdinando; Imbimbo, Ciro; Mirone, Vincenzo | |
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. | 1.1 Articolo in rivista | 2008 | Di Lorenzo, G; Figg, Wd; Fossa, Sd; Mirone, Vincenzo; Autorino, R; Longo, Nicola; Imbimbo, Ciro; Perdonà, S; Giordano, A; Giuliano, Mario; Labianca, R; DE PLACIDO, Sabino | |
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections. | 1.1 Articolo in rivista | 2009 | Mirone, Vincenzo; Fusco, Ferdinando; Taglialatela, D; Verze, Paolo; Di Vito, C; Lotti, T; Imbimbo, Ciro | |
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study. | 1.1 Articolo in rivista | 2009 | Fusco, Ferdinando; Sicuteri, R; Rossi, A; Kontodimas, S; Haro, Jm; Imbimbo, Ciro; Mirone, Vincenzo | |
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals. | 1.1 Articolo in rivista | 2009 | Imbimbo, Ciro; Verze, P; Palmieri, Alessandro; Longo, Nicola; Fusco, Ferdinando; Arcaniolo, D; Mirone, Vincenzo | |
Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients | 1.1 Articolo in rivista | 2009 | Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, N; Imbimbo, Ciro; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino | |
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? | 1.1 Articolo in rivista | 2010 | Novara, G; Ficarra, V; Antonelli, A; Artibani, W; Bertini, R; Carini, M; Cosciani Cunico, S; Imbimbo, Ciro; Longo, Nicola; Martignoni, G; Martorana, G; Minervini, A; Mirone, Vincenzo; Montorsi, F; Schiavina, R; Simeone, C; Serni, S; Simonato, A; Siracusano, S; Volpe, A; Carmignani, G. | |
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition. | 1.1 Articolo in rivista | 2010 | Fusco, Ferdinando; Razzoli, E; Imbimbo, Ciro; Rossi, A; Verze, Paolo; Mirone, Vincenzo | |
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation | 1.1 Articolo in rivista | 2003 | Perretti, A.; Catalano, A.; Mirone, Vincenzo; Imbimbo, C.; Balbi, P.; Palmieri, A.; Longo, N.; Mirone, V. | |
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas | 1.1 Articolo in rivista | 1999 | Cindolo, L.; Benvenuto, G.; Salavatore, P.; Pero, Raffaela; Salvatore, G.; Mirone, Vincenzo; Prezioso, D. | |
Determinants of Erectile Dysfunction Risk in a Large Series of Italian Men Attending Andrology Clinics | 1.1 Articolo in rivista | 2004 | Mirone, Vincenzo; Ricci, E.; Gentile, V.; Basile Fasolo, C.; Parazzini, F.; Calabrese, M. | |
Frequency and determinants of erectile dysfunction in Italy | 1.1 Articolo in rivista | 2000 | Mirone, Vincenzo; Colli, E.; Parazzini, F. | |
Androgens and benign prostatic hyperplasia | 1.1 Articolo in rivista | 2006 | Mirone, Vincenzo; Fusco, Ferdinando; Verze, P.; Schulman, C.; Debruyne, F.; Imbimbo, Ciro | |
The benefits of dual inhibition of 5 alpha reductase | 1.1 Articolo in rivista | 2006 | B., Djavan; Mirone, Vincenzo | |
How do new data from clinical trials allow us to optimise the assessment and treatment of patients with benign prostatic hyperplasia? | 1.1 Articolo in rivista | 2007 | Mirone, Vincenzo | |
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression | 1.1 Articolo in rivista | 2001 | Stanzione, R.; Picascia, A.; Chieffi, P.; Imbimbo, Ciro; Palmieri, A.; Mirone, Vincenzo; Staibano, S. | |
Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study. | 1.1 Articolo in rivista | 2003 | Ricci, E; Parazzini, F; Mirone, Vincenzo; Imbimbo, C; Palmieri, A; Bortolotti, A; DI CINTIO, E; Landoni, M; Lavezzari, M. | |
Erectile dysfunction after surgical treatment. | 1.1 Articolo in rivista | 2003 | Mirone, Vincenzo; Imbimbo, C; Palmieri, A; Longo, N; Fusco, Ferdinando | |
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. | 1.1 Articolo in rivista | 2003 | Perretti, A; Catalano, A; Mirone, Vincenzo; Imbimbo, C; Balbi, P; Palmieri, A; Longo, N; Fusco, Ferdinando; Verze, P; Santoro, Lucio |